10-K Decoder · All companies

Caribou Biosciences, Inc.

CRBU · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$11.2M$9.99M+11.7%
Operating income−$148M−$167M+11.0%
Net income−$148M−$149M+0.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$1.60M$2.20M−27.3%
Operating income−$27.6M−$29.4M+6.1%
Net income−$26.6M−$27.5M+3.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Caribou's revenue in FY2025?
$11.2M in FY2025 (Fiscal year ended Dec 31, 2025), +11.7% vs $9.99M a year earlier, per its 10-K filed Mar 2026.
Was Caribou profitable in FY2025?
No: net income was −$148M and operating income −$148M in FY2025.
What was Caribou's revenue in Q3 2026?
$1.60M (−27.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.